Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients신장 이식 환자에서 MRNA-1273 SARS-CoV-2 백신 후 세포 및 체액 반응Article Published on 2021-08-012022-09-11 Journal: American journal of transplantation : official jou [Category] MERS, SARS, 진단, 치료법, [키워드] antibody antithymocyte baseline cellular cellular response Clinical research clinical research / practice develop diabete diabetes Effect elicit ELISPOT Factor had no humoral IgG IgM IgM/IgG Infection infection and infectious agents - viral infectious agent infectious agents Infectious disease kidney kidney transplant recipient kidney transplant recipients kidney transplantation / nephrology Moderna mRNA mRNA-1273 naïve Nephrology offer Patient Preliminary data prospectively studied question receiving recipient Research S protein SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine second dose Seroconversion seronegative patient seronegative patients side Side effects the S protein Transplant Treatment Trial vaccination Vaccine [DOI] 10.1111/ajt.16701 PMC 바로가기 [Article Type] Article
T cell-mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19COVID-19 이전에 간 이식 환자에서 SARS-CoV-2에 대한 T 세포 매개 반응Article Published on 2021-08-012022-09-11 Journal: American journal of transplantation : official jou [Category] MERS, SARS, 진단, 치료기술, [키워드] 1:1 acute respiratory syndrome age antigens CD4 CD8 Cell-mediated immunity cell-mediated response clinical research/practice Complication complication: infectious control group coronavirus COVID-19 COVID-19 diagnosis cytokine declining Diagnosis ELISA ICS IgG antibodies IgG responses immune immune modulation Immunosuppression immunosuppression/immune modulation impair Infection infection and infectious agents infection and infectious agents - viral infectious infectious agent infectious agents Infectious disease interferon intracellular cytokine staining inverse correlation liver Liver transplantation liver transplantation/hepatology magnitude median membrane membrane protein monitoring: immune. MOST no significant difference no significant differences p value Patient patients proportion recipient recipients respiratory response SARS-CoV-2 SARS-CoV-2 IgG antibody Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus SFU Spearman T cell were measured [DOI] 10.1111/ajt.16708 PMC 바로가기 [Article Type] Article
Cytomegalovirus antiviral stewardship in the COVID-19 Era: Increasing complexity of prophylaxis and treatment and potential mitigation strategiesCOVID-19 시대의 거대 세포 바이러스 항바이러스 관리: 예방 및 치료의 복잡성 증가 및 잠재적 완화 전략Review Published on 2021-08-012022-09-11 Journal: Transplant infectious disease : an official journa [Category] SARS, 치료제, [키워드] Antiviral approach approaches Betacoronavirus Care cause CMV Complication Contact COVID-19 COVID-19 pandemic cytomegalovirus disease evaluate evidenced global pandemic healthcare Increasing Infection infection and infectious agents infectious agents Intervention Laboratory morbidity and mortality novel Betacoronavirus organ transplantation outcome pandemic physical distancing Prophylaxis quality of care/care delivery recipients reduce Respiratory Coronavirus SARS-CoV-2 severe acute respiratory coronavirus severe acute respiratory coronavirus 2 solid organ solid organ transplant solid organ transplantation SOT Streamline Treatment Vigilance Viral viral infection viral: cytomegalovirus. [DOI] 10.1111/tid.13586 PMC 바로가기 [Article Type] Review
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients흉부 이식 수혜자의 2회 용량 SARS-CoV-2 메신저 RNA 백신 BNT162b2에 대한 체액 및 T 세포 반응 불량Original Paper Published on 2021-07-092022-09-11 Journal: Clinical Research in Cardiology [Category] MERS, 진단, 치료법, [키워드] Abbott age analysed anti-SARS-CoV-2 average BioNTech/Pfizer (BNT162b2) vaccine blood sample Blood samples BNT162b2 BNT162b2 vaccine booster dose cellular response control group COVID-19 infection detectable domain domains dose ELISA Euroimmun Evidence evidence of excluded exhibited functional Genscript healthy heart humoral IgG immune response immune responses immunoassays Immunocompromised patient Immunocompromised patients immunogenicity Immunoglobulin infectious agent infectious agents inhibitory interferon interferon-γ lung majority membrane protein Messenger RNA Neutralizing antibodies neutralizing antibody nucleocapsid Organ transplant Patient patients peptides Pfizer-BioNTech Poor prime Qiagen QuantiFERON recipient recipients robust SARS-CoV-2 Seroconversion shown significant increase Specific T-cell response Spike protein stimulated T-cell T-cell Response tested titre Transplant recipients vaccination Vaccine Vaccines Viral viral spike was measured Whole blood [DOI] 10.1007/s00392-021-01880-5 PMC 바로가기 [Article Type] Original Paper
Increased Adherence to Infection Control Practices Among Medical Laboratory Technicians During the COVID-19 Pandemic: A Self-Reported Survey StudyOriginal Research Published on 2021-06-252022-10-27 Journal: Annals of Global Health [Category] COVID-19, [키워드] addition adherence clinical sample Control COVID-19 COVID-19 pandemic equipment Face masks Frequency Government handling Health include Increased infection control infectious agents Jordan lab Laboratory laboratory technician majority participant Participants Patient Personal protective equipment PPE Practice reducing reported risk significantly study population survey Technician was used [DOI] 10.5334/aogh.3378 PMC 바로가기 [Article Type] Original Research
Increased Adherence to Infection Control Practices Among Medical Laboratory Technicians During the COVID-19 Pandemic: A Self-Reported Survey StudyOriginal Research Published on 2021-06-252022-10-27 Journal: Annals of Global Health [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] addition adherence clinical sample Control COVID-19 COVID-19 pandemic equipment Face masks Frequency Government handling Health include Increased infection control infectious agents Jordan lab Laboratory laboratory technician majority participant Participants Patient Personal protective equipment PPE Practice reducing reported risk significantly study population survey Technician was used [DOI] 10.5334/aogh.3378 PMC 바로가기 [Article Type] Original Research
Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 PandemicEditorial Published on 2021-06-202022-10-28 Journal: Advanced Pharmaceutical Bulletin [Category] COVID-19, [키워드] addition age Alter aspect Autoimmune disease caused Chronic diseases clinical complex correlation disease drug treatment Express global pandemic Hyperinflammatory immune immunomodulating immunomodulating drug increased risk Infection infectious agents Inflammation Inflammatory bowel disease inhibit inhibiting inhibitor key factor knowledge likelihood mechanism of action Necrosis paradoxical Patient Pharmacology physician progression recognize reduce rheumatoid arthritis risk factor SARS-CoV-2 SARS-COV-2 infection Severe case spondylitis subject the disease therapeutic efficacy therapy TNF TNF inhibitors Topic [DOI] 10.34172/apb.2021.045 PMC 바로가기 [Article Type] Editorial
Could a New COVID-19 Mutant Strain Undermine Vaccination Efforts? A Mathematical Modelling Approach for Estimating the Spread of B.1.1.7 Using Ontario, Canada, as a Case StudyArticle Published on 2021-06-032022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] B.1.1.7 Canada change characterized Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-2019 cumulative Efficacy Emerging infectious diseases event Evolution high mutation rate Host Immunity imperative implication infectious agents Infectious disease infectious disease outbreak Intervention mathematical mathematical model mutant Mutant strains New new strain outbreak pandemic pathogen populations Prevent public health reported respiratory responsible SARS-CoV-2 Spread strain Strains Taking unlikely vaccination Vaccine variant viruses wild-type strain [DOI] 10.3390/vaccines9060592 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO 2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and ProteinArticle Published on 2021-05-202022-10-28 Journal: Viruses [Category] COVID-19, SARS, [키워드] absence adverse effect aerosol Aerosols Compound contaminated surface COVID-19 damage decrease disease-causing Disinfection Effect effective for disinfection Genome global pandemic Health Human infectious agents Radiation reduced RNA RNA damage RT-qPCR SARS-CoV-2 SARS-CoV-2 inactivation Spread surface TiO2 photocatalyst toxicities transmission electron microscopy transmitted Treatment ultraviolet C viral morphology disruption Viral protein viral protein damage virion virus [DOI] 10.3390/v13050942 PMC 바로가기 [Article Type] Article
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic체계적인 검토: SARS-CoV-2/COVID-19 범유행의 낭포성 섬유증Research Article Published on 2021-05-202022-09-10 Journal: BMC Pulmonary Medicine [Category] 변종, [키워드] acute exacerbation acute respiratory syndrome acute respiratory syndrome coronavirus Affect affected angiotensin Angiotensin-converting enzyme Clinical course conducted Consequences coronavirus Course COVID-19 COVID-19 incidence cystic fibrosis determine disease disease outbreaks estimate Evidence evidenced expression fibrosis General population H1N1 H1N1 pandemic higher risk include indicated individual Infection Infection prevention infectious agents life-threatening Lung disease medications morbidity organ transplants Outbreaks pandemic populations Potential precipitated Prevention and control protective mechanism protective mechanisms Recurrent required respiratory respiratory tract respiratory viral infection respiratory viral infections Result risk risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe COVID-19 social isolation subset systematic literature search transplantation Viral viral infections [DOI] 10.1186/s12890-021-01528-0 PMC 바로가기 [Article Type] Research Article